£1.0M
The funding round was secured from the MEIF Proof of Concept and Early Stage Fund alongside Mercia and angel investors to support global growth.
"PHARMASEAL aims to give customers increased control over their clinical trials and product development. This second round of investment demonstrates the confidence that investors have in our product and will enable us to scale up our commercial operations."
